Tocagen (Replicating Gene Therapy Platform and Related Assets) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Tocagen (Replicating Gene Therapy Platform and Related Assets) General Information

Description

A portfolio of assets consisting of replicating gene therapy platform and related assets. The acquired asset uses an innovative approach utilizing a proprietary gene therapy platform, RRV, combined with a prodrug, to selectively infect and kill cancer cells while stimulating a robust and durable anti-cancer immune response against a tumor with minimal toxicity.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 4242 Campus Point Court
  • Suite 600
  • San Diego, CA 92121
  • United States
Primary Industry
Buildings and Property
Other Industries
Diagnostic Equipment
Pharmaceuticals
Acquirer
Denovo Biopharma
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 4242 Campus Point Court
  • Suite 600
  • San Diego, CA 92121
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tocagen (Replicating Gene Therapy Platform and Related Assets) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tocagen (Replicating Gene Therapy Platform and Related Assets)‘s full profile, request access.

Request a free trial

Tocagen (Replicating Gene Therapy Platform and Related Assets) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Tocagen (Replicating Gene Therapy Platform and Related Assets)‘s full profile, request access.

Request a free trial

Tocagen (Replicating Gene Therapy Platform and Related Assets) FAQs

  • Where is Tocagen (Replicating Gene Therapy Platform and Related Assets) headquartered?

    Tocagen (Replicating Gene Therapy Platform and Related Assets) is headquartered in San Diego, CA.

  • What industry is Tocagen (Replicating Gene Therapy Platform and Related Assets) in?

    Tocagen (Replicating Gene Therapy Platform and Related Assets)’s primary industry is Buildings and Property.

  • Is Tocagen (Replicating Gene Therapy Platform and Related Assets) a private or public company?

    Tocagen (Replicating Gene Therapy Platform and Related Assets) is a Private company.

  • What is Tocagen (Replicating Gene Therapy Platform and Related Assets)’s current revenue?

    The current revenue for Tocagen (Replicating Gene Therapy Platform and Related Assets) is .

  • Who are Tocagen (Replicating Gene Therapy Platform and Related Assets)’s investors?

    Tocagen has invested in Tocagen (Replicating Gene Therapy Platform and Related Assets).

  • When was Tocagen (Replicating Gene Therapy Platform and Related Assets) acquired?

    Tocagen (Replicating Gene Therapy Platform and Related Assets) was acquired on 28-Apr-2020.

  • Who acquired Tocagen (Replicating Gene Therapy Platform and Related Assets)?

    Tocagen (Replicating Gene Therapy Platform and Related Assets) was acquired by Denovo Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process